Drug Profile
Tc 99m nitridocade
Alternative Names: CISNOET; Tc99m-NOET; TcN-NOETLatest Information Update: 05 May 2003
Price :
$50
*
At a glance
- Originator Bayer Schering Pharma
- Class Organotechnetium compounds; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Technetium compounds; Thiocarbamates
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Coronary artery disease
Most Recent Events
- 05 May 2003 Discontinued - Phase-III for Coronary artery disease diagnosis in France (IV)
- 05 May 2003 Discontinued - Phase-III for Coronary artery disease diagnosis in USA (IV)
- 06 Apr 2001 Phase-III clinical trials for Coronary artery disease diagnosis in USA (IV)